Research Paper Volume 16, Issue 10 pp 8697—8716
A cuproptosis-based prognostic model for predicting survival in low-grade glioma
Figure 11. Immune checkpoints and chemotherapy sensitivity. (A–M) Relationship between risk model and immunological checkpoints. (N) Immunotherapy response and risk score. (O–Q) Chemotherapy sensitivity and risk score.